|
GB8808015D0
(en)
|
1988-04-06 |
1988-05-05 |
Ritter M A |
Chemical compounds
|
|
AU643427B2
(en)
|
1988-10-31 |
1993-11-18 |
Immunex Corporation |
Interleukin-4 receptors
|
|
AU665763B2
(en)
|
1991-05-03 |
1996-01-18 |
Seragen, Inc. |
Interleukin receptor targeted molecules for treatment of inflammatory arthritis
|
|
JP3315427B2
(ja)
|
1992-03-05 |
2002-08-19 |
大日本除蟲菊株式会社 |
皮膚炎治療剤
|
|
US5714146A
(en)
|
1992-08-26 |
1998-02-03 |
Board Of Regents Of The University Of Washington |
IL-4 bone therapy
|
|
EP0604693A1
(en)
|
1992-12-29 |
1994-07-06 |
Schering-Plough |
Monoclonal antibodies against the human interleukin-4 receptor and hybridomas producing the same
|
|
RU2162711C2
(ru)
|
1993-09-07 |
2001-02-10 |
Смитклайн Бичам Корпорейшн |
Рекомбинантные il4-антитела, используемые для лечения нарушений, связанных с действием il4
|
|
ES2259478T3
(es)
|
1998-09-18 |
2006-10-01 |
Dynavax Technologies Corporation |
Metodos para tratar trastornos asociados con la ige y composiciones para este uso.
|
|
DE16192152T1
(de)
|
2000-05-26 |
2020-08-06 |
Immunex Corporation |
Verwendung von interleukin-4 rezeptor (il-4r) antikörpern und zusammensetzungen davon
|
|
US20020002132A1
(en)
*
|
2000-05-26 |
2002-01-03 |
Pluenneke John D. |
Use of interleukin-4 antagonists and compositions thereof
|
|
US7879328B2
(en)
|
2000-06-16 |
2011-02-01 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to B lymphocyte stimulator
|
|
DE60130466T2
(de)
|
2000-07-26 |
2008-06-12 |
Hououdou Co. Ltd. |
Antipruritische zusammensetzungen und die wundheilung fördernde zusammensetzungen
|
|
US20030103938A1
(en)
|
2001-05-09 |
2003-06-05 |
Alk-Abello A/S |
Pharmaceutical compositions for preventing or treating Th1 and Th2 cell related diseases by modulating the Th1/Th2 ratio
|
|
EP1390067A1
(en)
|
2001-05-11 |
2004-02-25 |
Novartis AG |
Compositions for use in treating ige-associated disorders
|
|
CA2447795A1
(en)
|
2001-05-23 |
2002-11-28 |
Duotol Ab |
Suppression of allergic reactions by transdermal administration of allergens in conjunction with or conjugated to toxin subunits or fragments thereof
|
|
DK1461300T3
(da)
|
2001-11-30 |
2011-10-24 |
Biogen Idec Inc |
Antistoffer mod kemotaktiske monocytproteiner
|
|
CN1326879C
(zh)
|
2002-03-29 |
2007-07-18 |
先灵公司 |
人源抗白细胞介素5单克隆抗体及其制备方法和包含这些抗体的组合物
|
|
ES2575547T3
(es)
|
2003-02-01 |
2016-06-29 |
Tanox, Inc. |
Anticuerpos anti-IgE de humano de alta afinidad
|
|
US7923209B2
(en)
|
2003-03-14 |
2011-04-12 |
Anergis, S.A. |
Allergen peptide fragments and use thereof
|
|
GEP20104991B
(en)
|
2003-11-07 |
2010-05-25 |
Immunex Corp |
Antibodies that bind interleukin-4 receptor
|
|
AU2004309373A1
(en)
|
2003-12-22 |
2005-07-14 |
Amgen Inc. |
Methods for identifying functional antibodies
|
|
CA2554596A1
(en)
|
2004-02-27 |
2005-09-15 |
Regeneron Pharmaceuticals, Inc. |
Il-4/il-13 specific polypetides and therapeutic uses thereof
|
|
US20090098142A1
(en)
|
2004-06-09 |
2009-04-16 |
Kasaian Marion T |
Methods and compositions for treating and monitoring treatment of IL-13-associated disorders
|
|
TWI307630B
(en)
|
2004-07-01 |
2009-03-21 |
Glaxo Group Ltd |
Immunoglobulins
|
|
JP5234445B2
(ja)
|
2004-10-05 |
2013-07-10 |
源一郎 杣 |
薬剤
|
|
WO2006083390A2
(en)
|
2004-12-07 |
2006-08-10 |
Children's Hospital Medical Center |
Eotaxin-3 in eosinophilic esophagitis
|
|
TW200902555A
(en)
|
2005-01-03 |
2009-01-16 |
Hoffmann La Roche |
Antibodies against IL-13 receptor alpha 1 and uses thereof
|
|
US8324192B2
(en)
|
2005-11-12 |
2012-12-04 |
The Regents Of The University Of California |
Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
|
|
US8679545B2
(en)
|
2005-11-12 |
2014-03-25 |
The Regents Of The University Of California |
Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
|
|
JP4221018B2
(ja)
|
2006-08-31 |
2009-02-12 |
トヨタ自動車株式会社 |
頭部保護エアバッグ装置
|
|
WO2008054606A2
(en)
|
2006-10-02 |
2008-05-08 |
Regeneron Pharmaceuticals, Inc. |
High affinity human antibodies to human il-4 receptor
|
|
US7608693B2
(en)
|
2006-10-02 |
2009-10-27 |
Regeneron Pharmaceuticals, Inc. |
High affinity human antibodies to human IL-4 receptor
|
|
RU2500686C2
(ru)
|
2007-03-22 |
2013-12-10 |
Дженентек, Инк. |
АПОПТОТИЧЕСКИЕ АНТИТЕЛА ПРОТИВ IgE
|
|
EP2022507A1
(en)
|
2007-08-07 |
2009-02-11 |
Universität Hamburg |
Antibody compositions specific for lgE, lgG4 and lgA epitopes as tools for the design of hypoallergenic molecules for specific immunotherapy
|
|
WO2009061819A1
(en)
|
2007-11-05 |
2009-05-14 |
The Regents Of The University Of Colorado |
Minimally-invasive measurement of esophageal inflammation
|
|
US8092804B2
(en)
|
2007-12-21 |
2012-01-10 |
Medimmune Limited |
Binding members for interleukin-4 receptor alpha (IL-4Rα)-173
|
|
DE202008006598U1
(de)
|
2008-04-11 |
2008-10-02 |
Alk-Abelló A/S |
Allergie-Impfstoff-Formulierung zur mucosalen Verabreichung
|
|
US20090264392A1
(en)
|
2008-04-21 |
2009-10-22 |
Meritage Pharma, Inc. |
Treating eosinophilic esophagitis
|
|
EP2376656A4
(en)
|
2008-12-01 |
2012-05-16 |
Cincinnati Children S Hospital Medical Ct |
METHOD AND DETERMINATION OF THE EFFECTIVENESS OF A GLUCOCORTICOID TREATMENT OF EOSINOPHILIAN ESOPHAGITIS
|
|
EP2414520A2
(en)
|
2009-03-31 |
2012-02-08 |
Altair Therapeutics, Inc. |
Methods of modulating an immune response to a viral infection
|
|
US8497528B2
(en)
|
2010-05-06 |
2013-07-30 |
Taiwan Semiconductor Manufacturing Company, Ltd. |
Method for fabricating a strained structure
|
|
AU2010291171B2
(en)
|
2009-09-07 |
2015-10-29 |
Dbv Technologies |
Method of treating eosinophilic esophagitis
|
|
US8993347B2
(en)
|
2009-12-17 |
2015-03-31 |
Cornell University |
Methods for detecting antibodies in mucosal samples and device for sampling mucosal material
|
|
WO2011163614A2
(en)
|
2010-06-24 |
2011-12-29 |
Meritage Pharma, Inc. |
Methods of treatment for esophageal inflammation
|
|
PL2624865T3
(pl)
|
2010-10-06 |
2018-11-30 |
Regeneron Pharmaceuticals, Inc. |
Stabilizowane preparaty zawierające przeciwciała przeciwko receptorowi interleukiny-4 (IL-4R)
|
|
RU2453303C1
(ru)
|
2010-12-23 |
2012-06-20 |
Общество с ограниченной ответственностью "ЦитоНИР" (ООО "ЦитоНИР") |
Фармацевтическая композиция для лечения атопического дерматита
|
|
CA2824043A1
(en)
|
2011-01-06 |
2012-07-12 |
Marc E. Rothenberg |
Esophageal cytokine expression profiles in eosinophilic esophagitis
|
|
US20130052190A1
(en)
|
2011-02-22 |
2013-02-28 |
Oxagen Limited |
CRTH2 Antagonists for Treatment of Eosinophilic Diseases and Conditions
|
|
AU2012272858B2
(en)
|
2011-06-21 |
2017-03-09 |
Children's Hospital Medical Center |
Diagnostic methods for eosinophilic esophagitis
|
|
CN103974706A
(zh)
|
2011-10-06 |
2014-08-06 |
N·V·努特里奇亚 |
嗜酸细胞性食管炎的治疗
|
|
SG11201402796SA
(en)
|
2011-12-16 |
2014-06-27 |
Atopix Therapeutics Ltd |
Combination of crth2 antagonist and a proton pump inhibitor for the treatment of eosinophilic esophagitis
|
|
AR091305A1
(es)
|
2012-01-31 |
2015-01-28 |
Genentech Inc |
ANTICUERPOS ANTI-IgE Y SUS METODOS DE USO
|
|
WO2013155010A1
(en)
|
2012-04-09 |
2013-10-17 |
Children's Hospital Medical Center |
Non-invasive biomarkers for eosinophilic esophagitis
|
|
WO2014031610A1
(en)
|
2012-08-21 |
2014-02-27 |
Sanofi |
Methods for treating or preventing asthma by administering an il-4r antagonist
|
|
HRP20181227T1
(hr)
*
|
2012-09-07 |
2018-10-05 |
Regeneron Pharmaceuticals, Inc. |
Metode za liječenje atopijskog dermatitisa primjenom antagonista il-4r
|
|
WO2014059178A1
(en)
|
2012-10-10 |
2014-04-17 |
Rhode Island Hospital |
Differential expression of novel protein markers for the diagnosis and treatment of eosinophilic esophagitis
|
|
ES2667420T3
(es)
|
2013-02-05 |
2018-05-10 |
Engmab Sàrl |
Anticuerpos biespecíficos contra cd3epsilon y bcma
|
|
TWI755763B
(zh)
|
2013-06-04 |
2022-02-21 |
美商再生元醫藥公司 |
藉由投與il-4r抑制劑以治療過敏及增強過敏原-特異之免疫療法的方法
|
|
TWI634900B
(zh)
|
2013-07-11 |
2018-09-11 |
再生元醫藥公司 |
藉由投與ｉｌ－４ｒ抑制劑治療嗜酸性食道炎的方法
|
|
RU2552929C1
(ru)
|
2013-11-14 |
2015-06-10 |
Общество С Ограниченной Ответственностью "Фарминтерпрайсез" |
Фармацевтическая композиция, содержащая производные глутаримидов, и их применение для лечения эозинофильных заболеваний
|
|
IL315136A
(en)
|
2014-02-21 |
2024-10-01 |
Sanofi Biotechnology |
Methods for treating or preventing asthma by administering an il-4rantagonist
|
|
RU2704999C2
(ru)
|
2014-02-28 |
2019-11-01 |
Ридженерон Фармасьютикалз, Инк. |
Способ лечения кожной инфекции путем введения антагониста il-4r
|
|
PT3613432T
(pt)
|
2014-05-07 |
2025-10-29 |
Regeneron Pharma |
Métodos para tratar a polipose nasal através da administração de um antagonista de il-4r
|
|
US10066017B2
(en)
|
2014-11-14 |
2018-09-04 |
Sanofi Biotechnology |
Methods for treating chronic sinusitis with nasal polyps by administering an IL-4R antagonist
|
|
MA44238B1
(fr)
|
2016-02-19 |
2024-07-31 |
Regeneron Pharmaceuticals, Inc. |
Procédés d'augmentation de l'efficacité d'un vaccin par administration d'un antagoniste d'il-4r
|
|
TWI777515B
(zh)
|
2016-08-18 |
2022-09-11 |
美商愛戴爾製藥股份有限公司 |
治療嗜伊紅性食道炎之方法
|
|
CN109789196B
(zh)
|
2016-09-01 |
2024-03-19 |
瑞泽恩制药公司 |
用于通过施用il-4r拮抗剂来预防或治疗变态反应的方法
|
|
CN118203659A
(zh)
|
2016-09-22 |
2024-06-18 |
瑞泽恩制药公司 |
用于通过施用il-4r抑制剂治疗严重特应性皮炎的方法
|
|
CN110461335A
(zh)
|
2017-02-17 |
2019-11-15 |
弗雷德哈钦森癌症研究中心 |
用于治疗bcma相关癌症和自身免疫性失调的联合疗法
|
|
US20200179511A1
(en)
|
2017-04-28 |
2020-06-11 |
Novartis Ag |
Bcma-targeting agent, and combination therapy with a gamma secretase inhibitor
|
|
WO2019028367A1
(en)
|
2017-08-04 |
2019-02-07 |
Regeneron Pharmaceuticals, Inc. |
METHODS OF TREATING ESOPHAGITIS WITH ACTIVE EOSINOPHILES
|
|
PT3515465T
(pt)
|
2017-08-18 |
2024-03-04 |
Regeneron Pharma |
Métodos para o tratamento de uma dermatite atópica grave mediante a administração de um inibidor de il-4r
|
|
PL3703818T3
(pl)
|
2017-10-30 |
2024-03-25 |
Sanofi Biotechnology |
Antagonista IL-4R do zastosowania w sposobie leczenia lub zapobiegania astmie
|
|
EP3793597A1
(en)
|
2018-05-13 |
2021-03-24 |
Regeneron Pharmaceuticals, Inc. |
Methods for treating atopic dermatitis by administering an il-4r inhibitor
|
|
MA55372A
(fr)
|
2019-03-21 |
2022-01-26 |
Regeneron Pharma |
Combinaison d'inhibiteurs de la voie il-4/il-13 et d'ablation de plasmocytes pour traiter une allergie
|
|
CN114173819A
(zh)
|
2019-08-05 |
2022-03-11 |
瑞泽恩制药公司 |
通过施用il-4r拮抗剂治疗过敏和增强过敏原特异性免疫疗法的方法
|
|
AU2020326713A1
(en)
|
2019-08-05 |
2022-02-17 |
Regeneron Pharmaceuticals, Inc. |
Methods for treating atopic dermatitis by administering an il-4r antagonist
|
|
EP4073810A1
(en)
|
2019-12-09 |
2022-10-19 |
Sanofi Biotechnology |
Methods for treating digitally-identified il-4/il-13 related disorders
|
|
KR20230015965A
(ko)
|
2020-05-22 |
2023-01-31 |
리제너론 파아마슈티컬스, 인크. |
Il-4r 억제제를 투여함에 의해 호산구성 식도염을 치료하기 위한 방법
|
|
WO2022150605A1
(en)
|
2021-01-08 |
2022-07-14 |
Regeneron Pharmaceuticals, Inc. |
Methods for treating peanut allergy and enhancing peanut allergen-specific immunotherapy by administering an il-4r antagonist
|